Nicardipine and verapamil in essential hypertension

I. M. Al-Khawaja; M. P. Caruana; A. Lahiri; J. R. Whittington; J. G. Lewis; E. B. Raftery

Back

Other

Nicardipine and verapamil in essential hypertension

I. M. Al-Khawaja, M. P. Caruana, A. Lahiri, J. R. Whittington, J. G. Lewis and E. B. Raftery

01/01/1986

PMCID: PMC1401060

Abstract

The Treatment of Hypertension

1 Nicardipine 30 mg three times daily and verapamil 160 mg twice daily have been compared in 30 patients with essential hypertension using a two-period crossover clinical trial with 6 week treatment periods.

Metrics

1 Record Views

Details

Title: Nicardipine and verapamil in essential hypertension
Creators - without role: I. M. Al-Khawaja
M. P. Caruana
A. Lahiri
J. R. Whittington
J. G. Lewis
E. B. Raftery
Identifiers: 9929451008331
Academic Unit: Taibah University
Language: English
Resource Type: Other